Integral Diagnostics (Integral Diagnostics) Cash-to-Debt : 0.05 (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Integral Diagnostics Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Integral Diagnostics's cash to debt ratio for the quarter that ended in Dec. 2023 was 0.05.

If Cash to Debt ratio is less than 1, the company cannot pay off its debt using the cash in hand. Here we can see, Integral Diagnostics couldn't pay off its debt using the cash in hand for the quarter that ended in Dec. 2023.

The historical rank and industry rank for Integral Diagnostics's Cash-to-Debt or its related term are showing as below:

ITGDF' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.05 Med: 0.21 Max: 0.38
Current: 0.05

During the past 8 years, Integral Diagnostics's highest Cash to Debt Ratio was 0.38. The lowest was 0.05. And the median was 0.21.

ITGDF's Cash-to-Debt is ranked worse than
93.97% of 232 companies
in the Medical Diagnostics & Research industry
Industry Median: 1.35 vs ITGDF: 0.05

Integral Diagnostics Cash-to-Debt Historical Data

The historical data trend for Integral Diagnostics's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Integral Diagnostics Cash-to-Debt Chart

Integral Diagnostics Annual Data

Trend

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Cash-to-Debt

Get a 7-Day Free Trial

0.15

0.21

0.20

0.36

0.09

Integral Diagnostics Semi-Annual Data
	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Cash-to-Debt	Get a 7-Day Free Trial												0.16	0.36	0.10	0.09	0.05

Competitive Comparison of Integral Diagnostics's Cash-to-Debt

For the Diagnostics & Research subindustry, Integral Diagnostics's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Integral Diagnostics's Cash-to-Debt Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Integral Diagnostics's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where Integral Diagnostics's Cash-to-Debt falls into.

Integral Diagnostics Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Integral Diagnostics's Cash to Debt Ratio for the fiscal year that ended in Jun. 2023 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	22.721	/	(11.187	+	233.831)
	=	0.09

Integral Diagnostics's Cash to Debt Ratio for the quarter that ended in Dec. 2023 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	12.04	/	(11.97	+	229.993)
	=	0.05

Integral Diagnostics (OTCPK:ITGDF) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

Integral Diagnostics Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of Integral Diagnostics's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Integral Diagnostics (Integral Diagnostics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Integral Diagnostics Ltd (OTCPK:ITGDF) » Definitions » Cash-to-Debt

Comparable Companies

Traded in Other Exchanges

IDX:Australia

Address

45 William Street, Suite 9.02, Level 9, Melbourne, VIC, AUS, 3000

Website

http://www.integraldiagnostics.com.au

Integral Diagnostics is Australia's fourth-largest diagnostic imaging provider. In Australia, imaging revenues are almost entirely earned via the public health Medicare system. Integral typically earns approximately 90% of group revenue from diagnostic imaging in Australia and the remainder from diagnostic imaging in Auckland, New Zealand. In Australia, Integral services regional areas in Queensland, Victoria, New South Wales, and Western Australia.